HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

被引:357
作者
Mazzoli, S
Trabattoni, D
Caputo, SL
Piconi, S
Ble, C
Meacci, F
Ruzzante, S
Salvi, A
Semplici, F
Longhi, R
Fusi, ML
Tofani, N
Biasin, M
Villa, ML
Mazzotta, F
Clerici, M
机构
[1] UNIV MILAN, PADIGL LITA, CATTEDRA IMMUNOL, I-20157 MILAN, ITALY
[2] OSPED SM ANNUNZIATA, ASL 10, CTR MST UO MALATTIE INFETT, I-50100 FLORENCE, ITALY
[3] OSPED L SACCO, DIV MALATTIE INFETT 1, I-21057 MILAN, ITALY
[4] CNR, IST CHIM ORMONI, I-20131 MILAN, ITALY
关键词
D O I
10.1038/nm1197-1250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-specific mucosal and cellular immunity was analyzed in heterosexual couples discordant for HIV status in serum and in HIV-unexposed controls. HIV-specific IgA but not IgG was present in urine and vaginal wash samples from HIV-exposed seronegative individuals (ESN), whereas both IgA and IgG were observed in their HIV-seropositive partners; antibodies were not detected in low-risk controls. Envelope protein (Env) peptide-stimulated interleukin-2 (IL-2) production by peripheral blood mononuclear cells (PBMCs) was detected in 9 out of 16 ESNs, 5 out of 16 HIV-infected patients and 1 out of 50 controls. Env peptide-stimulated PBMCs of ESNs produced more IL-2 and less IL-10 compared with those of HIV-infected individuals; no differences were observed in chemokine production or in CCR5 expression. These data demonstrate that a compartmentalized immune response to pathogens is possible in humans and raise the possibility of protective roles for cell-mediated immunity and mucosal IgA in HIV-seronegative individuals exposed to HIV.
引用
收藏
页码:1250 / 1257
页数:8
相关论文
共 54 条
[21]   RISK FOR OCCUPATIONAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ASSOCIATED WITH CLINICAL-EXPOSURES - A PROSPECTIVE EVALUATION [J].
HENDERSON, DK ;
FAHEY, BJ ;
WILLY, M ;
SCHMITT, JM ;
CAREY, K ;
KOZIOL, DE ;
LANE, HC ;
FEDIO, J ;
SAAH, AJ .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (10) :740-746
[22]   WHETHER AND WHEN AN AIDS VACCINE [J].
HILLEMAN, MR .
NATURE MEDICINE, 1995, 1 (11) :1126-1129
[23]  
LANGLADEDEMOYEN P, 1994, J CLIN INVEST, V93, P1297
[24]   INDUCTION OF MUCOSAL AND SYSTEMIC IMMUNITY TO A RECOMBINANT SIMIAN IMMUNODEFICIENCY VIRAL PROTEIN [J].
LEHNER, T ;
BERGMEIER, LA ;
PANAGIOTIDI, C ;
TAO, L ;
BROOKES, R ;
KLAVINSKIS, LS ;
WALKER, P ;
WALKER, J ;
WARD, RG ;
HUSSAIN, L ;
GEARING, AJH ;
ADAMS, SE .
SCIENCE, 1992, 258 (5086) :1365-1369
[25]   Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques [J].
Lehner, T ;
Wang, YF ;
Cranage, M ;
Bergmeier, LA ;
Mitchell, E ;
Tao, L ;
Hall, G ;
Dennis, M ;
Cook, N ;
Brookes, R ;
Klavinskis, L ;
Doyle, C ;
Ward, R .
NATURE MEDICINE, 1996, 2 (07) :767-775
[26]   Genital and rectal mucosal immunity against transmission of SIV/HIV [J].
Lehner, T ;
Bergmeier, LA ;
Brookes, R ;
Hussain, L ;
Klavinskis, L ;
Mitchell, E ;
Tao, L .
ESSENTIALS OF MUCOSAL IMMUNOLOGY, 1996, :437-447
[27]   Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8(+) T cells [J].
Levy, JA ;
Mackewicz, CE ;
Barker, E .
IMMUNOLOGY TODAY, 1996, 17 (05) :217-224
[28]   HIV PATHOGENESIS AND LONG-TERM SURVIVAL [J].
LEVY, JA .
AIDS, 1993, 7 (11) :1401-1410
[29]   Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil [J].
Guerra Corado, Andre de Lima ;
Villarouco da Silva, George Allan ;
Carvalho Leao, Renato Augusto ;
Granja, Fabiana ;
Naveca, Felipe Gomes .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (03) :314-315
[30]   INTRACELLULAR NEUTRALIZATION OF VIRUS BY IMMUNOGLOBULIN-A ANTIBODIES [J].
MAZANEC, MB ;
KAETZEL, CS ;
LAMM, ME ;
FLETCHER, D ;
NEDRUD, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :6901-6905